Atlas Trials

Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis

Clinical trial NCT02015520 · COMPLETED

Trial details

NCT number
NCT02015520
Sponsor
CSL Behring
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2012-06-01
Primary completion
2013-06-01
Enrollment
143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.